Ezetimibe plus statin combination versus double-dose statin in patients with dyslipidemia and atherosclerotic cardiovascular disease risk: a comprehensive systematic review and meta-analysis of 47 randomized controlled trials
Sign Up to like & getrecommendations! Published in 2025 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2025.2487966
Abstract: Abstract Background Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Oral regimens to achieve blood lipid targets include increasing the statin dose or adding ezetimibe to statin therapy. The optimal strategy remains… read more here.
Keywords: dose statin; plus statin; risk; double dose ... See more keywords
Abstract 4138221: Ezetimibe plus statin combination vs. double dose statin for patients with dyslipidemia and ASCVD risk: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4138221
Abstract: Background: Dyslipidemia is a major risk factor for Atherosclerotic Cardiovascular Disease (ASCVD). Statin is a crucial intervention to fix dyslipidemia and reduce the ASCVD risk. Still, there are several regimens to achieve blood lipid level… read more here.
Keywords: dose statin; double dose; statin; ascvd risk ... See more keywords
High dose statin prophylaxis in cardiopulmonary bypass related surgery: clinical utility
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cardiothoracic Surgery"
DOI: 10.1186/s13019-017-0582-8
Abstract: BackgroundPrevious studies from our group demonstrated the anti-inflammatory properties of statins on cardiopulmonary bypass (CPB), through inhibition of neutrophil transendothelial migration. We sought to determine the utility of preoperative statin on patients undergoing cardiac surgery,… read more here.
Keywords: dose statin; surgery; high dose; cardiopulmonary bypass ... See more keywords